Evidence map›Paper›PMID 31791048›Full record

ArticlePloS one2019

Withdrawn medicines included in the essential medicines lists of 136 countries.

Onella Charles, Igho Onakpoya, Simran Benipal, Hannah Woods, Anjli Bali, Jeffrey K Aronson, Carl Heneghan, Nav Persaud

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations.Archives of public health = Archives belges de sante publique · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. A comparison of national essential medicines lists in the Americas.Revista panamericana de salud publica = Pan American journal of public health · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Onella CharlesMAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Canada.ORCID 0000-0002-1781-3994
Igho OnakpoyaCentre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Simran BenipalMAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Canada.
Hannah WoodsMAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Canada.ORCID 0000-0001-6143-0301
Anjli BaliMAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Canada.ORCID 0000-0002-0595-639X
Jeffrey K AronsonCentre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-1139-655X
Carl HeneghanCentre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-1009-1992
Nav PersaudMAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Canada.ORCID 0000-0003-3327-5580

Funding

CIHR
6 · The paper itself

Abstract

backgroundEssential medicines lists and related policies are intended to meet the priority health needs of populations and their implementation is associated with more appropriate use of medicines. The World Health Organization (WHO) recommends that countries carefully select the medicines to be included in their national essential medicines lists. Lists that are used to prioritize access to important treatments should not include medicines that have been withdrawn elsewhere because of an unfavourable benefit-to-harm balance; however, countries still list and use medicines that have been withdrawn worldwide. The objective of this study was to determine whether the national essential medicines lists of 137 countries include medicines that have been withdrawn in other countries. METHODS AND

findingsWe performed an audit of national essential medicines lists for medicines that had been withdrawn. Medicines withdrawn from worldwide markets between 1953 and 2014 were identified using a systematic review of published literature and regulatory documents. The reviewers used sources including the WHO's database of drugs, PubMed, and the websites of regulatory agencies to obtain information regarding adverse effects associated with the medicines, the year of first withdrawal, markets of withdrawal, and the level of evidence supporting each withdrawal. We recorded the number of countries with a withdrawn medicine included in their national medicines list, the number of withdrawn medicines included in each nation's list, and the number of national essential medicines including each withdrawn medicine. 97 medicines were withdrawn in at least one country but still included in one more national essential medicines list. Of 137 countries with a national essential medicines list, 136 lists included at least one withdrawn medicine, with 54% of the lists containing 5 or fewer withdrawn medicines, and 27% including 10 or more withdrawn medicines. 11 medicines were withdrawn worldwide but still included on at least one national essential medicines list. Countries with longer essential medicines lists had more withdrawn medicines included in their lists.

conclusionsThis study found that withdrawn medicines are included in all but one national essential medicines list, representing a need for more stringent processes for selecting and removing medicines on these lists. Countries may wish to apply special scrutiny to medicines withdrawn in other nations when selecting medicines to include on their lists.

Indexed as

Global HealthHealth PrioritiesSafety-Based Drug WithdrawalsCommunicationDatabases, FactualDrugs, EssentialHumansMedical AuditRecordsWorld Health OrganizationDrugs, Essential

Identifiers

PMID31791048
PMCPMC6887519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.